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Three Enterococcus faecalis and one Enterococcus faecium strains were characterized by plasmid profile, 
pulsed-field gel electrophoresis (PFGE) and determination of antimicrobial minimal inhibitory concentrations. 
VanA elements were characterized by Long PCR, overlapping PCR and DNA sequencing. Enterococcal strains 
showed resistance to vancomycin and harbored the vanA gene, and three these were teicoplanin susceptible while 
one showed intermediate resistance to teicoplanin. Two E. faecalis strains showed indistinguishable PFGE profile 
while the third was unrelated. E. faecalis strains showed a deletion in the right terminal region of the Tn1546-like 
element. The E. faecium strain showed an insertion element in the vanXY intergenic region. Mutations in VanA ele-
ments were not found. Rearrangements in the VanA element could be responsible for incongruities in genotype and 
phenotype in these strains. 
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Control of nosocomial infections caused by vanco-
mycin-resistant enterococci (VRE) has emerged as a 
worldwide health problem (Courvalin 2005, Vilela et 
al. 2006). Until the 1990s, most enterococcal infections 
could be successfully treated by a combination of vanco-
mycin and aminoglycosides antibiotics. As VREs have 
become more prevalent, treatment options have been 
greatly reduced (Schouten et al. 2000).
VanA and VanB are widespread globally and confer 
the most prevalent glycopeptide resistance phenotype 
(Courvalin 2005). The VanA phenotype is character-
ized by inducible, high-level resistance to vancomycin 
and teicoplanin. VanB-resistant strains are also inducible 
and resistant to vancomycin, but retain susceptibility to 
teicoplanin. Resistance phenotypes have been associated 
with the acquisition of two gene clusters, vanA and vanB. 
These gene clusters direct the synthesis of peptidoglycan 
precursors terminating with the depsipeptide D-alanyl-
D-lactate, which bind glycopeptide with reduced affinity 
(Arthur et al. 1996). 
The vanA gene cluster located on the Tn1546 mobile 
genetic element is 10,851 bp in size and encodes nine 
polypeptides that can be assigned to different functional 
groups. The products of vanA gene cluster include trans-
posase and resolvase (ORF 1 and ORF 2), VanS and 
VanR proteins, which are a response regulator and his-
tidine kinase sensor, respectively. VanH and VanA syn-
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thesize the depsipeptide D-alanyl-D-lactacte, VanX hy-
drolyses D-ala-D-ala, and VanY hydrolyzes the terminal 
D-ala residue from the peptidoglycan precursor protein. 
Vancomycin or teicoplanin induce autophosphorylation 
of VanS, which in turn phosphorylates VanR. Phospho-
rylated VanR protein binds to the promoter region of van-
HAX inducing transcription of genes encoding essential 
structural molecules (Arthur et al. 1992). The function of 
VanZ protein is unknown, but it has been related to tei-
coplanin resistance (Arthur et al. 1992, 1995).
Genetic heterogeneity in Tn1546-like element or VanA 
element has been documented (Hashimoto et al. 2000, 
Lee et al. 2004, Eom et al. 2004, Camargo et al. 2005). 
The polymorphisms described so far included mutations, 
insertion of insertions sequence (IS) and deletions.
In this study, the molecular characteristics of the 
Tn1546-like element in VanB phenotype-vanA geno-
type enterococccal strains isolated in Brazil are de-
scribed in order to advance understanding of the resis-
tance incongruities. 
Bacterial strains - Two VRE strains studied, Entero-
coccus faecalis 28 and Enterococcus faecium 172 were 
isolated in 1998 during an outbreak (Casa de Saúde San-
ta Marcelina, São Paulo, Brazil). The other two strains 
included in this study, E. faecalis 211 and E. faecalis 217 
were isolated in 2004 during a VRE surveillance pro-
gram at the Hospital Paulistano (Zanella et al. 2006). 
The enterococcal strains that are described in this report 
were isolated from different patients.
Species identification and susceptibility profile - 
The isolates were identified as Enterococcus spp. at the 
Instituto Adolfo Lutz (IAL), São Paulo, by conventional 
biochemical tests (Teixeira & Facklam 2003). Minimal 
inhibitory concentrations (MIC) for vancomycin and 
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teicoplanin were determined by agar dilution method 
according to the Clinical and Laboratory Standard In-
stitute (CLSI 2005) and by Etest (AB BIODISK). The 
vanA and vanB genotype were determined by multi-
plex polymerase chain reaction (PCR) (Woodford et al. 
1993). The strains were sent to the Laboratório Especial 
de Bacteriologia e Epidemiologia Molecular (LEBEM) 
at the Faculdade de Ciências Farmacêuticas of Ribeirão 
Preto – Universidade de São Paulo for confirmation of 
phenotype and genotype characterization. At LEBEM, 
the enterococcal species were confirmed using the pro-
tocol described by Dutka-Malen et al. (1995) followed 
by molecular characterization of the strains.
Pulsed-field gel electrophoresis (PFGE) profile - PFGE 
was performed after SmaI digestion of DNA (Campanile 
et al. 2003) in a Gene Navigator apparatus (Amersham, 
Uppsal, Sweden) at 180V for 25h at 7ºC with pulses of 20s 
for 10h, 8s for 10h and 3s for 5h. The DNA restriction pat-
terns were interpreted as previously described (Tenover 
et al. 1995).
Plasmid profile - Enterococci plasmid DNAs were 
extracted by the alkaline lysis method (Birnboim & 
Doly 1979) and analyzed by electrophoresis on 1% aga-
rose gels. Plasmid size was determined by comparison 
to plasmid standards from Escherichia coli V517 (NCTC 
50193) and E. coli 39R861 (NCTC 50192) strains. 
Location of VanA element - Southern blot hybridiza-
tion analysis was performed using digoxigenin-labeled 
DNA probes following procedures described in  the DIG 
System User Guide for filter hybridization (Boehringer, 
Mannheim, Germany). Southern blot hybridization was 
performed to determine molecular locations of the VanA 
element. Briefly, plasmid DNA was blotted onto nylon 
membranes (Hybond N+, Amersham) and hybridized 
with digoxigenin-labeled vanA probe (Woodford et al. 
1993). Also, genomic DNA digested with I-CeuI followed 
by PFGE was Southern blotted onto nylon membranes, 
and the blots were hybridized with digoxigenin- labeled 
vanA and 16S rRNA gene probes (Palazzo et al. 2006). 
Characterization of Tn1546-like elements - The char-
acterization of Tn1546- like elements was performed by 
Long PCR using the Expand Long Template PCR system 
(Boehringer, Mannheim, Germany) with a single prime 
target, the inverted repeat sequence of Tn1546 (Woodford 
et al. 1997). VanA elements in enterococci strains were 
characterized by overlapping PCR using ten pairs of PCR 
primers (Woodford & Stigter 1998). The PCR products of 
VanA resistance element were purified using a GFX kit and 
were sequenced using the MegaBaceTM apparatus (Amer-
sham Biosciences, Australia). E. faecium BM 4147, which 
carries a prototype of Tn1546, was used as a control. 
Determination of promoter - The vanXY intergenic 
region was amplified by PCR, using E. faecium 4147 
DNA as the template. It was cloned into a pKK232-8 
vector (Amersham Biosciences, Australia) containing 
the promoterless choramphenicol acetyltransferase (cat) 
gene. The amplification primers were Pz1 GGATC-
CGCTATTTTGATTTCCCCGTT and Pz2 GTCGAC-
CCTAAGTATATTAAGAATAAC, which contained cut 
sites for the restriction enzymes SalI and BamHI (under-
lined above). Restriction enzyme digestion is used to in-
sure DNA fragment correct orientation upstream to the 
cat gene. The PCR product and pKK 232-8 were both 
digested with SalI and BamHI enzymes and were ligat-
ed using T4 DNA ligase. The cloned product was trans-
fected by electroporation into E. coli DH10B, which was 
cultured in Luria Bertani (LB) broth for 1 h at 37ºC with 
gentle agitation. Subsequently, the cells were spread on 
LB agar plates supplemented with 10 µg/ml of cloram-
phenicol. Expression of the cat gene was used to demon-
strate presence of promoter.
Species identification and characterization of resis-
tance profile - Three isolates identified by multiplex PCR 
as E. faecalis 28, 211 and 217 showed high resistance to 
vancomycin and susceptibility to teicoplanin which es-
tablishes the VanB phenotype. The other isolate, identi-
fied as E. faecium 172 showed resistance to vancomycin 
and intermediate resistance to teicoplanin. Vancomycin 
and teicoplanin MICs for isolates are shown in Table. The 
multiplex PCR assay indicated the presence of a 399 bp 
product corresponding to the vanA gene in all entero-
cocci studied.
Analysis of clonality, plasmid profile and location of 
VanA element - E. faecalis 211 and 217, isolated during 
the 2004 surveillance showed indistinguishable PFGE 
profiles after SmaI digestion, indicating a single clone. E. 
faecalis 28 isolated in 1998 was genetically unrelated to 
these (Fig. 1). All strains showed the same plasmid 70 Kb 
plasmid (Fig. 2A). Southern blot hybridization with a 
vanA probe demonstrated presence of the vanA plasmid 
in E. faecium 172. The vanA probe hybridization with 
both fragments corresponding to chromosomal and plas-
mid DNA were shown by E. faecalis 211, E. faecalis 217 
and E. faecalis 28 (Fig. 2B) but different results were 
obtained in subsequent assays. No co-hybridization of 
the 16SrRNA and vanA probes after I-CeuI digestion 
of chromosomal DNA followed by PFGE indicated that 
those strains do not carry a copy of the vanA gene in 
their chromosomal DNA.
Molecular characterization of Tn1546-like elements 
- Characterization of Tn1546-like elements of the four 
VRE strains by Long PCR and overlapping PCR are 
summarized in Table. Three E. faecalis strains showed 
deletion of vanYZ genes and the right terminal repeat. E. 
faecium 172 showed insertion of an IS element, ISEfa5, 
between the vanX and vanY genes, located immediately 
after nucleotide 9,013 of Tn1546 and flanked by 8 bp di-
rect repeats, as previously reported by Camargo et al. 
(2005). According to the results obtained in this study, 
no promoter was detected between the vanX and vanY 
genes. DNA sequencing indicated the strains had no mu-
tations in vanS gene.
The VREs in this study were isolated in hospitals 
located in the city of São Paulo, Brazil, and showed 
incongruities in genotype and phenotype such as the 
VanB phenotype and the vanA genotype (Palazzo et al. 
2006, Zanella et al. 2006). The same incongruities have 
been described in studies conducted in Korea, Japan and 
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Taiwan. This suggests that point mutations in the vanS 
regulatory gene or impairment of VanY and VanZ ac-
cessory proteins may serve as mechanism for loss of tei-
coplanin resistance (Hashimoto et al. 2000, Lauderdale 
et al. 2002, Lee et al. 2004, Ko et al. 2005, Tanimoto et 
al. 2005, Song et al. 2006). Although E. faecalis 28, E. 
faecalis 211 and E. faecalis 217 presented VanB pheno-
type-vanA genotype, no mutation was found in the vanS 
gene (Hashimoto et al. 2000). 
The mechanism for VanZ protein associated teico-
planin resistance is unknown. Several authors (Arthur 
et al. 1994, Gold 2001, Courvalin 2006) reported that 
vanRSHAX genes promote cell wall alterations com-
patible with resistance to glycopeptides. These authors 
stated that the VanZ protein does not contribute to pro-
duce the pentadepsipeptide, the peptidoglycan precursor 
terminating in D-ala-D-lac, which is present in VRE 
strains (Arthur et al. 1995). Teicoplanin susceptibility 
in the strains in this study could be caused by genetic 
rearrangements in the right portion of Tn1546-like ele-
ments characterized by deletion of the vanY and vanZ 
genes which encode proteins important for the resistance 
mechanism in some situations. Thus, the denomination 
“accessory proteins” used in a majority of reports for 
products of vanY and vanZ genes are inadequate. 
Interestingly, E. faecium 172 contained an insertion 
of ISEfa5 in the intergenic region of vanXY genes, which 
could be the cause of the low-level resistance to teico-
planin. Other authors (Lee et al. 2004, Shin et al. 2006) 
have reported the presence of IS1216V in enterococci 
strains with the same phenotypic characteristics related 
to teicoplanin. The ISEfa5 insertion could interrupt a 
promoter preventing activation of vanY and vanZ genes 
Fig. 1: pulsed-field gel electrophoresis (PFGE) patterns after SmaI di-
gestion of total DNA extracted from the vancomycin resistant Entero-
coccus faecalis strains. Lanes -  M: molecular size weight (Lambda 
Ladder PFG Marker, New England Biolabs); 1-4: E. faecalis vanA (con-
trol strain), E. faecalis 28, E. faecalis 211, E. faecalis 217, respectively.
Fig. 2: agarose gel electrophoresis showing plasmid profiles and hybridization with the vanA probe. A: plasmid profiles of vancomycin resistant 
enterococcci (VRE) isolates after alkaline lyses extraction and agarose gel electrophoresis. Lines - 1-6: Escherichia coli 39R861; E. coli V517; 
E. faecalis 28; E. faecalis 211; E. faecalis 217; E. faecium 172, respectively; B: Southern blot corresponding to panel A and hybridization with 
vanA probe. Lines - 3-6: E. faecalis 28; E. faecalis 211; E. faecalis 217; E. faecium 172, respectively.
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by phosphorylated VanR protein as occur in vanH pro-
moter. Arguing against this is the fact that cloning analy-
ses do not indicate the presence of a promoter between 
vanX and vanY genes. Another possibility is deletion 
of genes after the ISEfa5 insertion. Refuting this is the 
fact that sequencing of the VanA element indicates that 
the vanX and vanY genes are intact. A more plausible 
explanation would be that the ISEfa5 insertion hinders 
activation of the transcription of vanY and vanZ genes 
by promoter H.
Molecular characterization of Tn1546-like elements 
is important to better understand VRE epidemiology. 
E. faecalis 28 isolated in Hospital Santa Marcelina in 
1998 shows the same Tn1546-like element and plasmid 
profile as strains E. faecalis 211 and E. faecalis 217 
which were isolated much later, in 2004 in a different 
hospital (Hospital Paulistano).
In conclusion, the endemic nature of VRE occurrence 
is a serious medical problem. Exchange of genetic material 
among enterococcal strains is very likely and exacerbates 
the problem. Structural integrity of the VanA element 
and the presence of vanY and vanZ genes are important to 
maintain the glycopeptide resistant phenotype. 
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